Hypera to divest Takeda products to Eurofarma

20 March 2020 - Deborah Wilkes

Premium

Brazil’s Hypera Pharma has agreed to sell some of the Latin American products it is acquiring from Japan’s Takeda to Eurofarma Laboratorios for USD161 million.

Click tags below for more information on topics:

Hypera Pharma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: